Zevra Therapeutics (ZVRA) Stock Chart & Stock Price History $7.21 -0.04 (-0.52%) As of 03:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Zevra Therapeutics Stock Price Performance 5 Day Performance-1.40%1 Month Performance-14.13%3 Month Performance-12.31%6 Month Performance-10.76%Year-To-Date Performance-15.47%1 Year Performance+54.61% Receive ZVRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Zevra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address ZVRA Stock Chart for Thursday, April, 24, 2025 ZVRA Chart by TradingView Zevra Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2025$7.31$7.25-0.82%$7.55$7.23462,788 shs$392.34 million04/22/2025$6.87$7.31+6.40%$7.37$6.93564,146 shs$395.59 million04/21/2025$7.15$6.87-3.92%$7.11$6.85363,613 shs$371.78 million04/18/2025$7.15$7.15$7.27$6.89406,058 shs$386.93 million04/17/2025$7.05$7.15+1.42%$7.27$6.89406,058 shs$386.93 million04/16/2025$6.96$7.05+1.29%$7.06$6.77338,170 shs$381.52 million04/15/2025$6.98$6.96-0.29%$7.15$6.90783,842 shs$376.65 million04/14/2025$6.90$6.98+1.16%$7.22$6.88388,088 shs$377.73 million04/11/2025$6.56$6.90+5.18%$6.95$6.52663,337 shs$373.40 million04/10/2025$6.85$6.56-4.23%$6.68$6.32380,642 shs$355.00 million Get the Latest News and Ratings for ZVRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Zevra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/09/2025$6.59$6.85+3.95%$7.02$6.19678,745 shs$370.70 million04/09/2025$6.59$6.85+3.95%$7.02$6.19678,745 shs$370.70 million04/08/2025$7.05$6.59-6.52%$7.40$6.55569,512 shs$356.62 million04/08/2025$7.05$6.59-6.52%$7.40$6.55569,512 shs$356.62 million04/07/2025$7.04$7.05+0.14%$7.41$6.63921,212 shs$381.52 million04/04/2025$7.43$7.04-5.25%$7.35$6.90580,412 shs$380.98 million04/03/2025$7.66$7.43-3.00%$7.53$7.30450,725 shs$402.08 million04/02/2025$7.32$7.66+4.64%$7.68$7.19577,002 shs$414.53 million04/01/2025$7.49$7.32-2.27%$7.63$7.26398,559 shs$396.13 million03/31/2025$7.85$7.49-4.59%$7.75$7.45431,811 shs$405.33 million03/28/2025$7.96$7.85-1.38%$7.99$7.77211,539 shs$424.81 million03/27/2025$7.85$7.96+1.40%$8.00$7.80362,407 shs$430.76 million03/26/2025$8.15$7.85-3.68%$8.21$7.78372,751 shs$424.81 million03/25/2025$8.21$8.15-0.73%$8.22$7.95235,760 shs$441.05 million03/24/2025$8.01$8.21+2.50%$8.33$8.07402,549 shs$444.29 million Related Companies Arcutis Biotherapeutics Stock Price Chart Arrowhead Pharmaceuticals Stock Price Chart ANI Pharmaceuticals Stock Price Chart IDEAYA Biosciences Stock Price Chart Apogee Therapeutics Stock Price Chart Kiniksa Pharmaceuticals Stock Price Chart Scilex Stock Price Chart ARS Pharmaceuticals Stock Price Chart Disc Medicine Stock Price Chart Immunocore Stock Price Chart Receive ZVRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Zevra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ZVRA) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredMusk’s real agenda in D.C. In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zevra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zevra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
